| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10307716 | Schizophrenia Research | 2014 | 5 Pages |
Abstract
Our results suggest that ziprasidone has a lower liability for inducing weight gain and lipid abnormalities than aripiprazole or quetiapine.
Keywords
Related Topics
Life Sciences
Neuroscience
Behavioral Neuroscience
Authors
Rocio Pérez-Iglesias, Victor Ortiz-Garcia de la Foz, Obdulia MartÃnez GarcÃa, Jose Antonio Amado, M. Teresa Garcia-Unzueta, Rosa Ayesa-Arriola, Paula Suarez-Pinilla, Rafael Tabares-Seisdedos, Benedicto Crespo-Facorro,